Covid-19 Respiratory Sequelae French Cohort

Summary

As the investigators need data on long term outcome of Covid-19, especially respiratory sequelae, a national cohort is required. To better evaluate the potential respiratory sequelae after SARS-CoV-2 infection, it is fundamental to include patients with different management at the acute phase of the Covid-19: ambulatory management, hospitalization in non ICU and in ICU units. That is why the investigators will conduct a national cohort study with all components of french pneumology which will give the investigators the opportunity to include patients in general hospital, in university hospital and in private structure. As it is a "real life" study, the investigators will include all patients who will have a consultation with a pneumologist for an evaluation 5 to 7 months after a Covid-19 infection whatever their acute disease management. The investigators will collect all available data on Covid-19 acute phase, on patients characteristics and comorbidities, on persistent symptoms after Covid-19, on exams results during the outcome evaluation (CT-scan, 6 min walk test, spirometry and DLCO, blood gas, VO2 max if realized).

Conditions

• COVID-19
• Fibrosis
• Cohort
• Follow-up
• Sequelae
• Spirometry DLCO

Sponsors & Collaborators

• Cabinet Medical valenciennes

  collaborator UNKNOWN

• CH Aix

  collaborator UNKNOWN

• hopital privé de bois bernard

  collaborator UNKNOWN

• Clinique La Croix du Sud

  collaborator UNKNOWN

• University Hospital, Bordeaux

  collaborator OTHER

• Hopital Forcilles

  collaborator OTHER

• Hopital d'instructions des armées

  collaborator UNKNOWN

• Hôpital Européen Marseille

  collaborator OTHER

• Rennes University Hospital

  collaborator OTHER

• Clinique Saint Augustin

  collaborator UNKNOWN

• Delafontaine Hospital

  collaborator OTHER

• Centre Hospitalier Universitaire de Saint Etienne

  collaborator OTHER

• Centre Hospitalier de Troyes

  collaborator OTHER

• Centre Hospitalier le Mans

  collaborator OTHER

• University Hospital, Clermont-Ferrand

  collaborator OTHER

• University Hospital, Tours

  collaborator OTHER

• Centre Hospitalier Universitaire, Amiens

  lead OTHER

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2021-10-07

Primary Completion

2023-04-01

Completion

2024-05-01

Countries

• France

Study Locations